US FDA approves Leqembi® IQKLIK ™ (lecanemab-irmb) subcutaneous injection for maintenance dosing for the treatment of early Alzheimer’s disease

STOCKHOLM, Aug. 29, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA-B) partner Eisai announced today the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for once weekly lecanemab subcutaneous injection for maintenance dosing. LEQEMBI IQLIK autoinjector is indicated for maintenance dosing to treat Alzheimer’s disease (AD) in patients with […]

Ouverture de la Big Data Expo 2025 à Guiyang, un événement mettant l’accent sur l’internationalisation, le professionnalisme et l’industrialisation

GUIYANG, Chine, 30 août 2025  /PRNewswire/ — Un article de presse de Huanqiu.com : Accueillie par l’Administration nationale des données et organisée par le gouvernement populaire de la province de Guizhou, l’Exposition internationale 2025 sur l’industrie du Big Data (la Big Data Expo 2025) s’est ouverte en grande pompe à Guiyang, la capitale de la province […]

Puerta de entrada al crecimiento: innovación y oportunidad en la 8ª CIIE

Aprovechando la plataforma vital para que las empresas globales accedan al enorme mercado chino, muchos expositores han pasado de ser participantes a inversores, mientras que numerosas exposiciones se han transformado en productos comercializables. Novartis, por ejemplo, presentó la Terapia de Radioligandos (RLT) en la 4ª CIIE. Aprovechando el impacto de la CIIE, firmó acuerdos estratégicos […]

EHC Investors Have Opportunity to Lead Encompass Health Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 29, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulting from allegations that Encompass Health may have issued materially misleading business information to the investing public. So what: If you purchased […]

ALZHEIMER’S ASSOCIATION WELCOMES FDA ACTION APPROVING LEQEMBI WEEKLY SUBCUTANEOUS MAINTENANCE DOSING

CHICAGO, Aug. 29, 2025 /PRNewswire/ — The Alzheimer’s Association welcomes today’s U.S. Food and Drug Administration (FDA) action to approve weekly subcutaneous maintenance dosing of Leqembi® (lecanemab, Eisai/Biogen) for early Alzheimer’s disease. With this approval, Leqembi IQLIK is the first monoclonal antibody that clears amyloid beta for the treatment of early Alzheimer’s disease that is approved […]

Centrus Energy to Participate in Upcoming Investor Events

BETHESDA, Md., Aug. 29, 2025 /PRNewswire/ — Centrus Energy Corp. (NYSE American: LEU) today announced that management will participate in the following upcoming conferences. On Tuesday, September 2, management is scheduled to host one-on-one investor meetings at the TD Securities Nuclear & Uranium Conference in London On Thursday, September 4, management is scheduled to host […]

E&R met en avant des technologies laser et plasma pour l’encapsulation avancée à SEMICON Taiwan 2025

KAOHSIUNG, 29 août 2025 /PRNewswire/ — Alors que l’IA, l’informatique haute performance et la 5G stimulent l’innovation dans le domaine des semi-conducteurs, l’encapsulation avancée est devenue le prochain axe stratégique. Le groupe Yole prévoit que le marché dépassera les 50 milliards d’USD d’ici 2025, avec une croissance annuelle de plus de 15 % pour les encapsulations fan-out […]

PicoCELA Inc. Issues Restricted Common Shares to MCC and You Planning

TOKYO, Aug. 30, 2025 /PRNewswire/ — On July 28, 2025, PicoCELA Inc. (“PicoCELA” or the “Company,”) (NASDAQ: PCLA), a Tokyo-based provider of enterprise wireless mesh solutions, entered into certain share subscription agreements (the “Share Subscription Agreements“) with MCC Venture Capital Limited Liability Company (“MCC“) and You Planning Limited Liability Company (“You Planning“), respectively. MCC and […]

PicoCELA Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

TOKYO, Aug. 30, 2025 /PRNewswire/ — PicoCELA Inc. (“PicoCELA” or the “Company”) (Nasdaq: PCLA), a Tokyo-based provider of enterprise wireless mesh solutions, today announced that the Company received a letter (the “Notification Letter”) from the Listings Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) on  August 26, 2025 , notifying the Company that it […]